There is a wealth of literature from epidemiological [64], clinical, and laboratory studies, suggesting the role of cholesterol metabolism in modulating APP processing promoting AD pathogenesis [65], but very little is known about the Aβ effect on modifying cellular cholesterol metabolism leading to neurodegeneration. The gene discussed is APP; the disease is Alzheimer disease.